Active Ingredient: ATRASENTAN HYDROCHLORIDE
Proprietary Name: VANRAFIA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 0.75MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N219208
Product Number: 001
Approval Date: Apr 2, 2025
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
